Tenax Therapeutics TENX
NASDAQ TENX
$1.89 +0.00 (+0.00%)
As of: Oct 1, 2026 · 11:52 AM EDT

Tenax Therapeutics (TENX) Accounts Payables (2011 - 2026)

Updated

Tenax Therapeutics' Accounts Payables came in at $6.8 million for Q2 2026, compared with $562,000 a year earlier and up 7.1% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Accounts Payables (2011 - 2026) Analysis & Trends

At the end of FY2025, Tenax Therapeutics' Accounts Payables was $6.04 million, up 91.4% from FY2024.

  • Accounts Payables has increased in each of the last three years, with a five-year compound annual growth rate of 51.5% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $3.16 million in FY2024 (+52.3%), $2.07 million in FY2023 (+167.5%), $775,045 in FY2022 (-9.8%) and $859,638 in FY2021 (+13.4%).
  • The Q2 2026 figure represents the highest quarterly Accounts Payables in data going back to Q4 2015.
  • Year-over-year, Accounts Payables increased in six of the last seven quarters, with growth averaging 159.7%.
  • The fastest year-over-year change in Accounts Payables over five years came in Q3 2024 (growth of 440.7%), and the weakest in Q1 2023 (a decline of 76.1%).
  • Business Quant data shows TENX's Accounts Payables at $6.35 million (Q1 2026), $6.04 million (Q4 2025) and $5.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Tenax Therapeutics 85.48 Mn 85.48 Mn - 6.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.80 Mn
Mar 31, 2026 6.35 Mn
Dec 31, 2025 6.04 Mn
Sep 30, 2025 5.61 Mn
Jun 30, 2025 562,000.00
Mar 31, 2025 1.84 Mn
Dec 31, 2024 3.16 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 869,656.00
Mar 31, 2024 1.08 Mn
Dec 31, 2023 2.07 Mn
Sep 30, 2023 292,961.00
Jun 30, 2023 271,633.00
Mar 31, 2023 307,922.00
Dec 31, 2022 775,045.00
Sep 30, 2022 265,407.00
Jun 30, 2022 919,384.00
Mar 31, 2022 1.29 Mn
Dec 31, 2021 859,638.00
Sep 30, 2021 776,247.00
API Access

Tenax Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TENX&period=max&api_key=YOUR_API_KEY